The fibrinolytic system facilitates tumor cell migration across the blood-brain barrier in experimental melanoma brain metastasis
2006

How Plasmin Helps Melanoma Cells Move to the Brain

publication Evidence: moderate

Author Information

Author(s): Perides George, Zhuge Yuzheng, Lin Tina, Stins Monique F, Bronson Roderick T, Wu Julian K

Primary Institution: Beth Israel Deaconess Medical Center, Harvard Medical School, and Tufts University School of Medicine

Hypothesis

The fibrinolytic enzyme plasmin plays a role in tumor cell migration across the blood-brain barrier and the growth of brain metastases.

Conclusion

Plasmin facilitates the development of tumor metastasis to the brain, and inhibiting the fibrinolytic system could help prevent this.

Supporting Evidence

  • Mice lacking plasminogen developed smaller tumors and survived longer than untreated mice.
  • Inhibition of plasmin with EACA resulted in smaller tumors in wild type mice.
  • Human melanoma cells crossed the blood-brain barrier in a plasmin-dependent manner.

Takeaway

This study found that a substance called plasmin helps cancer cells move into the brain, which can make the cancer worse. Blocking plasmin might help stop this from happening.

Methodology

The study used mouse models to investigate the role of plasmin in tumor cell migration and growth, employing both in vivo and in vitro experiments.

Statistical Information

P-Value

p<0.03

Statistical Significance

p<0.03

Digital Object Identifier (DOI)

10.1186/1471-2407-6-56

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication